Id1.2.276.0.76.11.516Gültigkeit ab2020‑05‑29 15:04:32
Canonical URIhttps://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/pharmacological-therapy-ops
Statusdraft EntwurfVersions-Label
Namedrug-therapy-opsBezeichnungMedikamentöse Therapie OPS
BeschreibungMedikamentöse Therapie im Rahmen von COVID-19, relevante OPS-Codes
Quell-Codesystem
1.2.276.0.76.5.487 - FHIR: urn:oid:1.2.276.0.76.5.487
Level/ TypCodeBezeichnung / Intentionale DefinitionCodesystem
 
circleplus Einfügen
descendants of code 6-005.m Tocilizumab, intravenös1.2.276.0.76.5.487
 
circleplus Einfügen
descendants of code 6-005.n Tocilizumab, subkutan1.2.276.0.76.5.487
 
circleplus Einfügen
descendants of code 6-004.e Temsirolimus, parenteral1.2.276.0.76.5.487
 
circleplus Einfügen
descendants of code 6-001.d Adalimumab, parenteral1.2.276.0.76.5.487
 
circleplus Einfügen
descendants of code 6-002.b Etanercept, parenteral1.2.276.0.76.5.487
 
circleplus Einfügen
descendants of code 6-001.e Infliximab, parenteral1.2.276.0.76.5.487
0‑L
6-005.m
Tocilizumab, intravenös
1.2.276.0.76.5.487
0‑L
6-005.n
Tocilizumab, subkutan
1.2.276.0.76.5.487
0‑L
6-00a.g
Sarilumab, parenteral
1.2.276.0.76.5.487
0‑L
6-005.8
Everolimus, oral
1.2.276.0.76.5.487
0‑L
6-004.e
Temsirolimus, parenteral
1.2.276.0.76.5.487
0‑L
6-001.d
Adalimumab, parenteral
1.2.276.0.76.5.487
0‑L
6-002.b
Etanercept, parenteral
1.2.276.0.76.5.487
0‑L
6-005.7
Certolizumab, parenteral
1.2.276.0.76.5.487
0‑L
6-005.2
Golimumab, parenteral
1.2.276.0.76.5.487
0‑L
6-001.e
Infliximab, parenteral
1.2.276.0.76.5.487
0‑L
6-006.7
Canakinumab, parenteral
1.2.276.0.76.5.487
0‑L
6-009.4
Ruxolitinib, oral
1.2.276.0.76.5.487
Legende: Typ L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavor OTH (other) schlägt Text in originalText vor. HL7 V3: NullFlavors werden im @nullFlavor Attribut statt in @code angegeben.
downloadXML JSON CSV SQL SVS FHIR (4.0)